Journal September 25, 2026 6 min read

How is the ketogenic diet measured?

The ketogenic diet is a high-fat, low-carbohydrate, adequate-protein dietary protocol whose metabolic state is defined by circulating ketone bodies. This page covers the analytes, sampling routes and models used to measu

peptides-pro Editorial

The ketogenic diet (KD) is a high-fat, low-carbohydrate, adequate-protein dietary protocol, sometimes described in the literature as a very-low-carbohydrate or ketogenic metabolic therapy. It is a dietary intervention rather than a single molecular entity, so it has no sequence, formula or molecular weight; what is measured instead is the metabolic state it produces, principally the ketone bodies acetoacetate, beta-hydroxybutyrate and acetone, together with the substrates and products of the pathways that generate them. Ketone bodies are produced by hepatic fatty acid oxidation and ketogenesis and are transported to extrahepatic tissues for oxidation, so measurement in research spans blood, breath, urine and tissue.

The work centres on hepatic mitochondrial fatty acid oxidation and the ketogenic pathway, with downstream readouts in neurotransmitter, glucose and xenobiotic-metabolising systems.

Research Studies

Ketogenic diet and blood versus breath metabolite measurement in metabolic conditions

In patients with inborn errors of metabolism (IEM) and in patients requiring a ketogenic diet for the treatment of medical conditions, relevant biochemical analytes are routinely and regularly measured in venous or capillary blood samples. Repeated venipuncture is invasive, burdensome and resource-intensive, and while capillary sampling relieves some of that burden for a limited number of metabolites, the frequent finger pricks required can still be uncomfortable. A registered study is therefore examining whether non-invasive breath measurements could replace the currently invasive biochemical measurements in these populations [3].

Sampling route	Population described	Stated limitation
Venous blood	IEM patients; patients on a ketogenic diet for medical conditions	Invasive, burdensome, resource-intensive
Capillary blood	Same	Frequent finger pricks remain uncomfortable
Breath	Same	Under investigation as a non-invasive alternative

Ketogenic diet and ketone levels during accelerated iTBS in treatment-resistant depression

A clinical trial in adults with treatment-resistant depression is comparing a ketogenic diet combined with personalised accelerated intermittent theta-burst stimulation (iTBS) against iTBS combined with a Canadian Food Guide-aligned diet. Among the questions it aims to answer is whether the ketogenic diet changes ketone levels over time, alongside whether the combination improves depression symptoms more than the comparator and whether the diet is safe, tolerable and feasible to follow during accelerated iTBS treatment [2]. Ketone levels are thus an explicit, repeatedly sampled endpoint rather than an assumed consequence of the diet.

Ketogenic diet and preoperative weight loss before one anastomosis gastric bypass

A trial in patients with severe obesity is comparing three preoperative strategies before one anastomosis gastric bypass (OAGB): tirzepatide for 60 days, a ketogenic diet for 4 weeks, or standard care. The primary goal is to determine which approach produces the best weight loss one year after surgery, with safety, surgical outcomes and improvement of obesity-related conditions such as diabetes, high blood pressure and sleep apnea also evaluated [1]. The ketogenic arm is defined by a fixed 4-week duration, which is the measurement window for the intervention.

Ketogenic diet and alcohol intoxication: brain NAD and MRI readouts

A study is examining the effects of ketosis on brain functioning and the acute effects of alcohol. Participants undergo approximately 4 weeks of ketogenic diet intervention with three lab visits — before starting the diet, about 2 weeks after starting, and after 4 weeks on the diet — each including an alcohol tolerance test and blood draws, with magnetic resonance imaging at the first and third visits. The MRI is used to measure levels of nicotinamide adenine dinucleotide (NAD) in the brain [7]. Here the measured quantities are both behavioural and imaging-based, not ketones alone.

Medium chain triglyceride ketogenic diet and liver mitochondria in rats

An 8-week medium chain triglyceride ketogenic diet (MCT-KD) was investigated for its effects on liver mitochondrial respiratory chain activity and cytochrome P450 2E1 (CYP2E1) expression in young and aged Fisher 344 × Brown Norway F1 rats. CYP2E1 is induced by the ketone body acetone and contributes to oxidative and carbonyl stress, but prior studies of CYP2E1 regulation during ketosis had yielded conflicting results. In young animals, MCT-KD significantly reduced mitochondrial complex I activity [4]. This is an animal study; the findings are not established in humans.

Ketogenic diet and neurotransmitter balance in a PTZ-induced zebrafish larvae model

Acute epilepsy was induced in 7-day post-fertilisation zebrafish larvae (n = 24 per group, randomly assigned) using pentylenetetrazol (PTZ), a selective GABA-A receptor antagonist, and a ketogenic diet was administered to the treatment group with behavioural assays performed [5]. The model was developed to investigate the diet's anti-epileptic potential and mechanisms, focusing on neurotransmitter homeostasis. This is a larval zebrafish model, not a human or mammalian one.

Ketogenic diet and glucose metabolism in cognitive aging: human trial evidence

A scoping review synthesised human interventions evaluating alternative energy substrates and nutrients that support cerebral energy metabolism and their effects on cognition in older adults, following PRISMA extension for scoping reviews guidelines. MEDLINE, EMBASE and Scopus were searched for studies published from 2014 to 2024 involving adults aged 60 years and older with mild cognitive impairment, Alzheimer's disease or subjective cognitive decline. The review is framed around cerebral glucose hypometabolism as a hallmark of cognitive aging and Alzheimer's disease [6].

Host metabolism and the intestinal microbiota

A paradigm paper proposes that intestinal homeostasis is a deterministic outcome orchestrated by host-mediated metabolic gating rather than stochastic microbial assembly, framing the host as an ecological engineer that shapes the microbiome through metabolism, and detailing three critical metabolic filters [8]. This is a conceptual framework rather than a measurement study, and it is included here because it bears on how diet-driven host metabolism is interpreted.

Danggui Shaoyao San and ketone body production in APP/PS1 mice

A study examined the mechanism by which Danggui Shaoyao San regulates hepatic fatty acid metabolism to promote ketone body production, transport and utilisation, thereby alleviating brain energy metabolism disorders in APP/PS1 mice and enhancing their cognitive abilities. Six SPF-grade 3-month-old male C57BL mice were used [9]. This is an animal study and is reported here as supporting context.

If you are reading this for personal health reasons

The materials described on this page are sold for laboratory research use only, and we do not provide dosing, dietary or medical guidance. Nothing here is a recommendation for any individual. Anyone considering a ketogenic diet or any related compound for themselves should speak to a licensed clinician.